| CCL20 | C-C motif chemokine ligand 20 |
| CCL12 | C-C motif chemokine ligand 12 |
| CCL5 | C-C motif chemokine ligand 5 |
| CSC | Cigarette smoke condensate |
| CX3CL1 | C-X3-C motif chemokine ligand I |
| ECC | E-cigarette smoke condensate |
| EC | Electronic cigarette, e-cigarette |
| ENDS | Electronic nicotine delivery system |
| EU | European Union |
| EVALI | E-vaping-associated lung injury |
| FDA | Food and Drug Administration |
| GIT | Gastrointestinal tract |
| HFD | High-fat diet |
| HNSCC | Head and neck squamous cell carcinoma |
| HGF | Human gingival fibroblast |
| LFT | Liver function test |
| IFN-ɣ | Interferon gamma |
| IL-10 | Interleukin-10 |
| MMP | Matrix metalloproteinase |
| NC | Nicotine-containing |
| NF | Nicotine-free |
| NFEC | Nicotine-free e-cigarette |
| SCC | Squamous cell carcinoma |
| OSCC | Oral squamous cell carcinoma |
| PG | Propylene glycol |
| VG | Vegetable glycerine |